<?xml version="1.0" encoding="UTF-8"?>
<ref id="B59-vaccines-07-00179">
 <label>59.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Julander</surname>
    <given-names>J.G.</given-names>
   </name>
   <name>
    <surname>Bantia</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Taubenheim</surname>
    <given-names>B.R.</given-names>
   </name>
   <name>
    <surname>Minning</surname>
    <given-names>D.M.</given-names>
   </name>
   <name>
    <surname>Kotian</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Morrey</surname>
    <given-names>J.D.</given-names>
   </name>
   <name>
    <surname>Smee</surname>
    <given-names>D.F.</given-names>
   </name>
   <name>
    <surname>Sheridan</surname>
    <given-names>W.P.</given-names>
   </name>
   <name>
    <surname>Babu</surname>
    <given-names>Y.S.</given-names>
   </name>
  </person-group>
  <article-title>BCX4430, a novel nucleoside analog, effectively treats yellow fever in a Hamster model</article-title>
  <source>Antimicrob. Agents Chemother.</source>
  <year>2014</year>
  <volume>58</volume>
  <fpage>6607</fpage>
  <lpage>6614</lpage>
  <pub-id pub-id-type="doi">10.1128/AAC.03368-14</pub-id>
  <pub-id pub-id-type="pmid">25155605</pub-id>
 </element-citation>
</ref>
